Biopharma Signs Multimillion-Dollar Deal for Key Products in China

Source: Streetwise Reports   08/08/2018 An H.C. Wainwright & Co. report reviewed the arrangement. In an August 6 research note, Jason Kolbert, an analyst with H.C. Wainwright & Co., reported that Can-Fite BioPharma Ltd. (CANF:NYSE.MKT) signed [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.